• Safe and Intriguing ‘Nature’s Drugs’ Taking on Complex Diseases

    Aug 6, 2024, 05:00 by User Not Found
    Clinical Research News | The cost of bringing a drug to market has, by some estimates, ballooned to $3 billion and the central problem could be the “misapplication of technology.” Since completion of the Human Genome Project, the focus had shifted heavily toward orphan drugs with a single genetic target, suitable only to highly targeted genetic technology platforms.
    Full story
  • Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows

    Aug 2, 2024, 07:59 by
    Indica Labs has announced the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.
    Full story
  • Leveraging Advanced Technologies for Clinical Trial Success

    Aug 2, 2024, 05:00 by User Not Found
    Clinical Research News | Clinical trials are a crucial step to advancing healthcare and bringing new treatments to patients. However, drug development is a lengthy, expensive, and high-risk proposition, and, according to PhRMA, a process that can take up to 15 years with an average cost exceeding $2 billion per new medicine.
    Full story
  • Trials ‘Still Largely White and Largely Male’ Due to Hidden Biases

    Jul 31, 2024, 05:00 by User Not Found
    Clinical Research News | Randomized clinical trials (RCTs) may need some serious revamping, based on mounting evidence of systemic biases afflicting the entire enterprise. Despite decades of efforts to realize equitable participation by marginalized groups, notably women and people of color, RCTs are “still largely white and largely male.”
    Full story
  • Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation

    Jul 30, 2024, 08:28 by
    Clinion, a Lifescience technology company based out of the US, UK and India, has won a category award in the 2024 Clinical Trials Arena Excellence Awards
    Full story
  • Sequence Biotech LLC Assumes Full Distribution of Sorenson Benchtop Pipettor

    Jul 30, 2024, 08:28 by
    Sequence Biotech LLC assumes Full Distribution of Sorenson Benchtop Pipettor. The 96 / 384 channel benchtop pipettor that has been used by industry giants for over a decade. Sequence Biotech is the original manufacturer of the "Sorenson Benchtop Pipettor."
    Full story
  • Youth Diabetes Researchers Invited to Dip Into POND, Make a Hypothesis

    Jul 30, 2024, 05:00 by User Not Found
    Clinical Research News | Soaring rates of youth prediabetes and diabetes over the past few decades have prompted a multidisciplinary team of experts from the Icahn School of Medicine at Mount Sinai (ISMMS) to create a dataset unifying potentially important clues about how to personalize interventions and devise better prevention strategies.
    Full story
  • Creative Enzymes Redefines Sustainability in Enzyme Innovation with Yeast-Fermented Vegan Collagen

    Jul 29, 2024, 08:28 by
    Full story
  • Inizio Engage and Nye Health form a strategic alliance to enhance patient support and outcomes

    Jul 29, 2024, 08:28 by
    Full story
  • Creative BioMart Expands Native Proteins Offering to Advance Scientific Research and Discovery

    Jul 29, 2024, 08:28 by
    Full story
  • Creative Enzymes Unveils Semaglutide, a Promising Solution for Comprehensive Diabetes Management

    Jul 29, 2024, 08:28 by
    Full story
  • Peerbridge Health Launches EF-ACT Pivotal Trial to Determine Ejection Fraction Severity from AI-Enabled Remote ECG Wearable

    Jul 25, 2024, 07:30 by
    Peerbridge Health Launches EF-ACT Pivotal Trial to Determine Ejection Fraction Severity from AI-Enabled Remote ECG Wearable
    Full story
  • Walgreens Receives Project Award, Oracle Announces New AI Capabilities for Trials, N-Power, Merck Collaborate on Oncology Clinical Research, More

    Jul 25, 2024, 05:00 by User Not Found
    Clinical Research News | Walgreens received a project award valued up to $25 million through the Rapid Response Partnership Vehicle to conduct a Phase IV observational clinical study focused on assessing Correlates of Protection; Oracle announced new capabilities in its AI-supported Oracle Argus and Safety One Intake solutions to help life science organizations meet evolving regulatory requirements and the rising volume of adverse event case workloads; Merck and N-Power Medicine has collaborated to enable a greater number of oncologists—and the patients they care for—to participate in clinical research; and more.
    Full story
  • Trial Approval for New Pacemaker Aiming to Boost Recovery in Heart Failure

    Jul 24, 2024, 08:12 by
    Ceryx Medica has announced the trial approval for Cysoni-XT, a new temporary cardiac pacemaker aiming to boost recovery in heart failure.
    Full story
  • SSI Strategy and Metalmind Partner for Enterprise AI Solutions

    Jul 24, 2024, 08:12 by
    SSI Strategy LLC has announced a partnership with MPS Metalmind AB emphasizing its commitment to leveraging cutting-edge artificial intelligence to drive innovation and enhance business capabilities.
    Full story
  • Cresset integrates Spark™ in latest release of Flare™ - from novel idea generation to extensive optimization

    Jul 24, 2024, 08:12 by
    Drug discovery specialists Cresset have launched the latest version of their drug discovery platform Flare, which aims to unleash the potential of creative molecule design in the early drug discovery process.
    Full story
  • Cardurion Pharmaceuticals’ Cardiovascular Trials, Cancer Resisting Monoclonal Antibodies, More

    Jul 24, 2024, 05:00 by User Not Found
    Clinical Research News | Cardurion Pharmaceuticals raises $260 million to support later-stage clinical trials with the company’s two lead drug candidates; CatalYm adds $150 million for phase 2b studies targeting checkpoint-naive and second-line treatment settings for solid tumors; and more.
    Full story
  • Biopharma PEG Announces Key Product Line of Monodispersed PEGs for Advanced Pharmaceutical Applications

    Jul 23, 2024, 08:17 by
    Biopharma PEG announces its advanced line of monodispersed PEGs, crucial for ADC and PROTAC linkers, as well as PEGylated proteins and peptides, enhancing pharmaceutical stability and delivery.
    Full story
  • Dexwell Showcases Coastal Protection Innovation with SeaPULSE Platform, Providing Hands-On Experience for Rady School of Business Interns

    Jul 23, 2024, 08:17 by
    Dexwell, Inc. has announced its SeaPULSE platform, a transformative tool in seawall maintenance, was utilized by interns from the Rady School of Business at UC San Diego, to advance their knowledge and contribute to seawater health research.
    Full story
  • PCR Biosystems Introduces Advanced Inhibitor-Tolerant qPCR Mixes for Superior Detection on Challenging Samples

    Jul 23, 2024, 08:17 by
    PCR Biosystems, a leading developer of PCR reagents, have launched a range of advanced inhibitor-tolerant mixes for probe-based qPCR and 1-step RT-qPCR. Available in the Clara® and Air-Dryable product lines to help researchers that work challenging, inhibitor-rich samples.
    Full story
  • «
  • 41
  • 42
  • 43 (current)
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • »